Info & imagens

BOTH ANTI-EGFR ANTIBODIES ARE SIMILARLY ACTIVE IN COMBINATION WITH IRINOTECAN IN METASTATIC COLORRETAL CANCER (MCRC) THAT HAVE PREVIOUSLY PROGRESSED ON IRINOTECAN

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Authors

Braghrioli, Maria Ignez

About the Journal

Journal: Brazilian Journal of Oncology

DOI: 10.1055/s-00059887

e-issn: 2526-8732

Publisher: Thieme Revinter Publicações Ltda.

Publisher address: Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

Conference

III Semana Brasileira da Oncologia

Local: Centro de Convenções de Salvador

Data: November 17, 2021